AAAAAA
Results: 26-37/37
Authors:
BOKEMEYER C
SCHMOLL HJ
HARSTRICK A
ILLIGER HJ
METZNER B
RATH U
HOHNLOSER J
CLEMM C
BERDEL W
SIEGERT W
RUTHER U
OSTERMANN H
KNEBA M
HARTLAPP JH
SCHRODER M
POLIWODA H
Citation: C. Bokemeyer et al., A PHASE I II STUDY OF A STEPWISE DOSE-ESCALATED REGIMEN OF CISPLATIN,ETOPOSIDE AND IFOSFAMIDE PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN PATIENTS WITH ADVANCED GERM-CELL TUMORS/, European journal of cancer, 29A(16), 1993, pp. 2225-2231
Authors:
BOKEMEYER C
SCHMOLL HJ
METZNER B
BEYER J
ILLIGER HJ
KNEBA M
OSTERMANN H
KYNAST B
RATH U
POLIWODA H
Citation: C. Bokemeyer et al., COMPARISON OF 5 VS 10 MU-G KG PER DAY OF GM-CSF FOLLOWING DOSE-INTENSIFIED CHEMOTHERAPY WITH CISPLATIN, ETOPOSIDE, AND IFOSFAMIDE IN PATIENTS WITH ADVANCED TESTICULAR CANCER/, Annals of hematology, 67(2), 1993, pp. 75-79
CAN SOMATOSTATIN RECEPTOR SCINTIGRAPHY CL OSE THE GAP IN LOCALIZATIONDIAGNOSIS IN CASE OF GASTRINOMA
Authors:
WURM K
DORR U
SAUTTERBIHL ML
GUZMAN G
BACH D
HORING E
RATH U
BIHL H
Citation: K. Wurm et al., CAN SOMATOSTATIN RECEPTOR SCINTIGRAPHY CL OSE THE GAP IN LOCALIZATIONDIAGNOSIS IN CASE OF GASTRINOMA, Tumordiagnostik & Therapie, 14(3), 1993, pp. 105-109
Authors:
DORR U
RATH U
SAUTTERBIHL ML
GUZMAN G
BACH D
ADRIAN HJ
BIHL H
Citation: U. Dorr et al., IMPROVED VISUALIZATION OF CARCINOID LIVER METASTASES BY IN-111 PENTETREOTIDE SCINTIGRAPHY FOLLOWING TREATMENT WITH COLD SOMATOSTATIN ANALOG, European journal of nuclear medicine, 20(5), 1993, pp. 431-433
Authors:
MUELLER M
MEYER M
VOLKMANN M
RATH U
KOMMERELL B
GALLE PR
Citation: M. Mueller et al., ANTI-P53 SERUM ANTIBODIES IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA AND GI-TRACT TUMORS - CLINICAL RELEVANCE AND DIAGNOSTIC USEFULNESS, Hepatology, 18(4), 1993, pp. 10000190-10000190
Authors:
VOLKMANN M
HOFMANN WJ
MULLER M
KLEIN R
WILLEMANN B
ZENTGRAF H
RATH U
GALLE PR
Citation: M. Volkmann et al., P53 IN EUROPEAN HEPATOCELLULAR-CARCINOMA - GENOMIC ALTERATIONS ASSOCIATED WITH INCREASED STEADY-STATE LEVELS AND HETEROGENOUS FUNCTIONAL-CHARACTERISTICS IN-VITRO, Hepatology, 18(4), 1993, pp. 10000196-10000196
Authors:
VOLKMANN M
MULLER M
HOFMANN WJ
MEYER M
HAGELSTEIN J
RATH U
KOMMERELL B
ZENTGRAF H
GALLE PR
Citation: M. Volkmann et al., THE HUMORAL IMMUNE-RESPONSE TO P53 IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA IS SPECIFIC FOR MALIGNANCY AND INDEPENDENT OF THE ALPHA-FETOPROTEIN STATUS, Hepatology, 18(3), 1993, pp. 559-565
Authors:
DORR U
RATH U
BACH D
BIHL H
Citation: U. Dorr et al., DETECTION OF NEUROENDOCRINE TUMORS OF THE GASTROINTESTINAL-TRACT BY MEANS OF SOMATOSTATIN RECEPTOR SCINTIGRAPHY, The Journal of nuclear medicine, 34(5), 1993, pp. 97-98
Authors:
RATH U
UPADHYAYA BK
ARECHAVALA E
BOCKMANN H
DEARNALEY D
DROZ JP
FOSSA SD
HENRIKSSON R
AULITZKY WE
JONES WG
WEISSBACH L
PASKA W
FREEMAN A
Citation: U. Rath et al., ROLE OF ONDANSETRON PLUS DEXAMETHASONE IN FRACTIONATED CHEMOTHERAPY, Oncology, 50(3), 1993, pp. 168-172
Authors:
DORR U
WURM K
HORING E
GUZMAN G
RATH U
BIHL H
Citation: U. Dorr et al., DIAGNOSTIC RELIABILITY OF SOMATOSTATIN RECEPTOR SCINTIGRAPHY DURING CONTINUOUS TREATMENT WITH DIFFERENT SOMATOSTATIN ANALOGS, Hormone and Metabolic Research, 27, 1993, pp. 36-43
Authors:
MUELLER M
MEYER M
ULSPERGER E
VOLKMANN M
RAINER H
RATH U
WERLE E
KOMMERELL B
GALLE PR
Citation: M. Mueller et al., CORRELATION OF PRESENCE OF ANTI-P53 SERUM ANTIBODIES WITH SURVIVAL INPATIENTS WITH GI-TUMORS, Gastroenterology, 104(4), 1993, pp. 431-431
Authors:
SCHERUBL H
RATH U
RIECKEN EO
KOMMERELL B
WIEDENMANN B
Citation: H. Scherubl et al., TREATMENT OF CARCINOID-TUMOR DISEASE WITH THE SOMATOSTATIN ANALOG LANREOTIDE, Gastroenterology, 104(4), 1993, pp. 447-447